Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since May 14 · below the Ichimoku cloud · RSI 31 · MACD above its signal · 1% above its 52-week low
None of the 29 investors followed here reported a position in WOK in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a WOK trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Sale at price 0.03 per share. | 136.7K | $4.37K |
| Jun 16, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 0.05 per share. | 880.5K | $40.50K |
| Jun 15, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Sale at price 0.06 per share. | 2.90M | $168.47K |
| Jun 14, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 0.10 per share. | 268.9K | $25.55K |
| Jun 11, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 0.08 per share. | 48.1K | $3.85K |
| Jun 10, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 0.09 - 0.10 per share. | 3.79M | $363.50K |
| Jun 8, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Sale at price 0.10 per share. | 3.46M | $363.62K |
| Jun 7, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 0.11 per share. | 2.26M | $239.68K |
| Jun 4, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 0.09 - 0.10 per share. | 1.42M | $148.92K |
| Jun 1, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Sale at price 0.11 per share. | 1.76M | $188.10K |
| May 31, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 0.14 per share. | 2.75M | $378.99K |
| May 28, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Sale at price 0.10 per share. | 2.62M | $261.96K |
| May 27, 2026 | Hrt Financial L.PBeneficial Owner of more than 10% of a Class of Security | Purchase at price 0.09 per share. | 1.54M | $138.23K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -28.4 | -14.1 | -10.4 | 0.8 | -92.2 | -79.5 | 2.1 | 13.7 | -21.0 | -21.5 | −99.4% | ||
| 2025 | -52.5 | -68.6 | -20.8 | -25.6 | 111.6 | -23.1 | 12.6 | 1.4 | -90.5 | -52.1 | 69.6 | -99.6 | −100.0% |
| 2024 | 6.9 | 16.7 | -8.8 | -11.9 | +0.2% |
No analyst coverage for this instrument.
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD has strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to develop data-model-application trinity for intelligent medical models. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.